These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 7731937)
21. Bcl-2 protein and DNA ploidy in renal cell carcinoma: do they affect patient prognosis? Skolarikos A; Alivizatos G; Bamias A; Mitropoulos D; Ferakis N; Deliveliotis C; Dimopoulos MA Int J Urol; 2005 Jun; 12(6):563-9. PubMed ID: 15985079 [TBL] [Abstract][Full Text] [Related]
22. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate. Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701 [TBL] [Abstract][Full Text] [Related]
23. DNA cytometry in renal cell carcinoma. Nenning H; Rassler J; Minh DH Gen Diagn Pathol; 1996 Mar; 141(3-4):243-7. PubMed ID: 8705789 [TBL] [Abstract][Full Text] [Related]
24. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder. Pantazopoulos D; Ioakim-Liossi A; Karakitsos P; Aroni K; Kakoliris S; Kanavaros P; Kyrkou KA Anticancer Res; 1997; 17(1B):781-6. PubMed ID: 9066620 [TBL] [Abstract][Full Text] [Related]
25. [Usefulness of DNA ploidy, AgNORs, PCNA and c-erbB-2 as predictors of prognosis in patients with renal cell carcinoma]. Tamaki M; Maeda S; Deguchi T; Kawada Y Hinyokika Kiyo; 1997 Oct; 43(10):697-702. PubMed ID: 9395903 [TBL] [Abstract][Full Text] [Related]
26. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma. Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282 [TBL] [Abstract][Full Text] [Related]
27. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas. Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696 [TBL] [Abstract][Full Text] [Related]
28. Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma. Visakorpi T J Pathol; 1992 Sep; 168(1):7-13. PubMed ID: 1360498 [TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry. Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053 [TBL] [Abstract][Full Text] [Related]
30. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers. Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725 [TBL] [Abstract][Full Text] [Related]
31. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma. Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492 [TBL] [Abstract][Full Text] [Related]
32. Renal cell carcinoma: a clinicopathological follow-up study after radical nephrectomy. Zubac DP; Bostad L; Gestblom C; Kihl B; Seidal T; Wentzel-Larsen T; Bakke AM Scand J Urol Nephrol; 2007; 41(3):191-7. PubMed ID: 17469026 [TBL] [Abstract][Full Text] [Related]
33. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility. Rodins K; Cheale M; Coleman N; Fox SB Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116 [TBL] [Abstract][Full Text] [Related]
34. DNA content of nasopharyngeal carcinoma: an independent prognostic indicator. Hsu MM; Chiou CR; Ko JY; Sheen TS; Hong RL; Ting LL Cancer Detect Prev; 2000; 24(2):119-26. PubMed ID: 10917131 [TBL] [Abstract][Full Text] [Related]
35. [Relationship between cellular DNA contents and cell proliferation of non-small cell lung cancer estimated by simultaneous quantification of PCNA and DNA contents by flow cytometer]. Morita K; Hayashi Y; Nagao S; Watanabe Y Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():164-7. PubMed ID: 7611782 [TBL] [Abstract][Full Text] [Related]
36. [Study of the prognostic value of DNA ploidy and proliferation index (Ki-67) in renal cell carcinoma with venous thrombus]. Rey D; Pfister C; Gobet F; Martinez S; Staerman F; Grise P Prog Urol; 2003 Dec; 13(6):1300-6. PubMed ID: 15000303 [TBL] [Abstract][Full Text] [Related]
37. Cytometric ploidy and proliferative activity in colorectal carcinoma. Grigolato P; Berenzi A; Benetti A; Chirico E; Cadei M; Casella C; Salerni B; Lojacono L Eur J Histochem; 1994; 38(2):163-70. PubMed ID: 7524813 [TBL] [Abstract][Full Text] [Related]
38. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer]. Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560 [TBL] [Abstract][Full Text] [Related]
39. [Expression and clinical significance of PCNA in renal pelvic and ureteral cancer]. Kong C; Li Z; Liu T Zhonghua Wai Ke Za Zhi; 1996 Oct; 34(10):614-6. PubMed ID: 9590738 [TBL] [Abstract][Full Text] [Related]
40. [Flow cytometric analysis of renal cell carcinoma]. Lü GH Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):27-9. PubMed ID: 2364867 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]